Featured Articles

  1. 2 Examples Reveal How 100% Decentralized Trials Are Rare, But Possible 11/2/2022

    Since the peak of the pandemic, the popularity of hybrid approaches has largely remained. However, fully decentralized trials are still somewhat rare. Learn why from these trial examples.

  2. Should You Incorporate Home Nurses Into Your Next Clinical Trial? 11/2/2022

    Explore why the clinical trials industry is shifting even further toward the routine incorporation of home visits into their studies.

  3. How Sponsors And CROs Can Fully Benefit From The Permanent Shift To Decentralized Home-Visit Clinical Trials 8/26/2022

    To aid sponsors and CROs in fully realizing the benefits of decentralized clinical trial methods moving forward, this whitepaper extracts the lessons learned from the pandemic and their implications for clinical trials now and in the future.

  4. Why The FDA Supports And Encourages Using Mobile Medical Professionals 8/25/2022

    We are finally at a turning point where increasing diversity and inclusiveness translates into action. Discover how DCTs can help to recruit and retain more diverse patient populations.

  5. How DCT Methods Address 5 Common Clinical Trial Challenges 8/25/2022

    Five common challenges in clinical trials include controlling costs, getting FDA approval, recruiting participants, retaining participants, and completing the trial on time. Learn more about each of these challenges and how DCTs can help overcome them. 

  6. The Value Of An Independent And Unaffiliated Partner For Mobile Clinical Trial Support 8/25/2022

    Despite growing consolidation in the clinical trials industry, learn why some mobile visit providers remain unaffiliated to provide independent service to sponsors and Contract Research Organizations (CROs).